All Products are stable to be shipped at room temperature, unless otherwise specified.
|Pack Size||Quantity||Price (USD)||Sub Total|
|Exact Weight Packaging||$ 95.00||0.0|
Product successfully added to cart.
- Request another packsize ? Click here.
- Inventory Status : Available in 2-3 weeks
- Ships On : 7/12/2022
Bulk Order Request for F335402
|Synonyms||(3E,5E,8S,9E,11S,12R,13E,15E,18S)-3-[[[6-Deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-β-D-mannopyranosyl]oxy]methyl]-12-[[6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-β-D-lyxo-hexopyranosyl]oxy]-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-oxacyclooctadeca-3,5,9,13,15-pentaen-2-one-D7; Clostomicin B1-D7; Dificid-D7; Dificlir-D7; Fidaxomicin-D7; Fidaxomycin-D7; Lipiarmicin-D7; Lipiarmycin-D7; Lipiarmycin-D7 A 3; OPT 80-D7; PAR 01-D7; PAR 101-D7; R-Tiacumicin B-D7; Tiacumicin B-D7|
|Alternate CAS #||Unlabelled: 873857-62-6|
|Melting Point||>123°C (dec.)|
|Solubility||DMSO (Slightly), Methanol (Slightly)|
|Category||Standards; Chiral Molecules; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Others; Pharmaceutical/API Drug Impurities/Metabolites; Antibotics;|
|Applications||Fidaxomicin-D7 is a labelled analogue of Fidaxomicin (F335400). Fidaxomicin is a nonabsorbed macrocyclic antibiotic, and is the first antimicrobial to be approved by the FDA for the treatment of Clostridium difficile infection (CDI) in 20 years. Fidaxomicin works by inhibiting sporulation by CDI, sustaining clinical response and reducing recurrences of this pathogen.|
|References||Babakhani, F., et al.: Clin. Infect. Dis., 55, S162 (2012); Venugopal, A., et al.: Clin. Infect. Dis., 54, 568 (2012)|